Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer.
Saved in:
| Title: | Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer. |
|---|---|
| Authors: | Albino D; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Falcione M; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Uboldi V; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Temilola DO; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Sandrini G; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Merulla J; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Civenni G; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Kokanovic A; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Stürchler A; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Shinde D; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Garofalo M; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padova, Italy., Mestre RP; Medical Oncology, Oncology Institute of Southern Switzerland, 6500, Bellinzona, Switzerland., Constâncio V; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal., Wium M; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Burrello J; Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, USI, Lugano, Switzerland., Baranzini N; Department of Biotechnology and Life Science, Università degli Studi dell'Insubria, Varese, Italy., Grimaldi A; Department of Biotechnology and Life Science, Università degli Studi dell'Insubria, Varese, Italy., Theurillat JP; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Bossi D; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Barile L; Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, USI, Lugano, Switzerland., Henrique RM; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal., Jeronimo C; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal., Zerbini LF; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Catapano CV; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland., Carbone GM; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland. pina.carbone@ior.usi.ch. |
| Source: | Communications biology [Commun Biol] 2021 Jan 26; Vol. 4 (1), pp. 119. Date of Electronic Publication: 2021 Jan 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33500545 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Albino+D%22">Albino D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Falcione+M%22">Falcione M</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Uboldi+V%22">Uboldi V</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Temilola+DO%22">Temilola DO</searchLink>; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Sandrini+G%22">Sandrini G</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Merulla+J%22">Merulla J</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Civenni+G%22">Civenni G</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kokanovic+A%22">Kokanovic A</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stürchler+A%22">Stürchler A</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shinde+D%22">Shinde D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Garofalo+M%22">Garofalo M</searchLink>; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Mestre+RP%22">Mestre RP</searchLink>; Medical Oncology, Oncology Institute of Southern Switzerland, 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Constâncio+V%22">Constâncio V</searchLink>; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Wium+M%22">Wium M</searchLink>; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Burrello+J%22">Burrello J</searchLink>; Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, USI, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Baranzini+N%22">Baranzini N</searchLink>; Department of Biotechnology and Life Science, Università degli Studi dell'Insubria, Varese, Italy.<br /><searchLink fieldCode="AU" term="%22Grimaldi+A%22">Grimaldi A</searchLink>; Department of Biotechnology and Life Science, Università degli Studi dell'Insubria, Varese, Italy.<br /><searchLink fieldCode="AU" term="%22Theurillat+JP%22">Theurillat JP</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bossi+D%22">Bossi D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Barile+L%22">Barile L</searchLink>; Laboratory for Cardiovascular Theranostics, Cardiocentro Ticino Foundation, USI, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Henrique+RM%22">Henrique RM</searchLink>; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Jeronimo+C%22">Jeronimo C</searchLink>; Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Zerbini+LF%22">Zerbini LF</searchLink>; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa and Integrative Biomedical Sciences Division, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Catapano+CV%22">Catapano CV</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Carbone+GM%22">Carbone GM</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI), 6500, Bellinzona, Switzerland. pina.carbone@ior.usi.ch. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101719179%22">Communications biology</searchLink> [Commun Biol] 2021 Jan 26; Vol. 4 (1), pp. 119. <i>Date of Electronic Publication: </i>2021 Jan 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+UK%22">Nature Publishing Group UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101719179 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2399-3642 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223993642%22">23993642 </searchLink><i>NLM ISO Abbreviation: </i>Commun Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33500545 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42003-020-01642-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 119 Titles: – TitleFull: Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Albino D – PersonEntity: Name: NameFull: Falcione M – PersonEntity: Name: NameFull: Uboldi V – PersonEntity: Name: NameFull: Temilola DO – PersonEntity: Name: NameFull: Sandrini G – PersonEntity: Name: NameFull: Merulla J – PersonEntity: Name: NameFull: Civenni G – PersonEntity: Name: NameFull: Kokanovic A – PersonEntity: Name: NameFull: Stürchler A – PersonEntity: Name: NameFull: Shinde D – PersonEntity: Name: NameFull: Garofalo M – PersonEntity: Name: NameFull: Mestre RP – PersonEntity: Name: NameFull: Constâncio V – PersonEntity: Name: NameFull: Wium M – PersonEntity: Name: NameFull: Burrello J – PersonEntity: Name: NameFull: Baranzini N – PersonEntity: Name: NameFull: Grimaldi A – PersonEntity: Name: NameFull: Theurillat JP – PersonEntity: Name: NameFull: Bossi D – PersonEntity: Name: NameFull: Barile L – PersonEntity: Name: NameFull: Henrique RM – PersonEntity: Name: NameFull: Jeronimo C – PersonEntity: Name: NameFull: Zerbini LF – PersonEntity: Name: NameFull: Catapano CV – PersonEntity: Name: NameFull: Carbone GM IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 01 Text: 2021 Jan 26 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2399-3642 Numbering: – Type: volume Value: 4 – Type: issue Value: 1 Titles: – TitleFull: Communications biology Type: main |
| ResultId | 1 |